Chemed Corporation $CHE Shares Purchased by L2 Asset Management LLC

L2 Asset Management LLC grew its stake in shares of Chemed Corporation (NYSE:CHE) by 85.9% in the fourth quarter, according to its most recent filing with the SEC. The fund owned 2,651 shares of the company’s stock after acquiring an additional 1,225 shares during the period. L2 Asset Management LLC’s holdings in Chemed were worth $1,134,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently modified their holdings of the company. Los Angeles Capital Management LLC acquired a new stake in shares of Chemed during the 4th quarter valued at $26,000. Smartleaf Asset Management LLC lifted its position in shares of Chemed by 71.4% during the 3rd quarter. Smartleaf Asset Management LLC now owns 60 shares of the company’s stock valued at $27,000 after acquiring an additional 25 shares during the last quarter. BOK Financial Private Wealth Inc. acquired a new stake in shares of Chemed during the 4th quarter valued at $27,000. Global Retirement Partners LLC lifted its position in shares of Chemed by 200.0% during the 4th quarter. Global Retirement Partners LLC now owns 87 shares of the company’s stock valued at $37,000 after acquiring an additional 58 shares during the last quarter. Finally, Rothschild Investment LLC lifted its position in shares of Chemed by 800.0% during the 4th quarter. Rothschild Investment LLC now owns 108 shares of the company’s stock valued at $46,000 after acquiring an additional 96 shares during the last quarter. Institutional investors and hedge funds own 95.85% of the company’s stock.

Insider Buying and Selling at Chemed

In other Chemed news, Director Andrea R. Lindell sold 1,347 shares of the business’s stock in a transaction on Tuesday, June 9th. The shares were sold at an average price of $447.33, for a total transaction of $602,553.51. Following the sale, the director directly owned 4,578 shares of the company’s stock, valued at $2,047,876.74. The trade was a 22.73% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Kevin J. Mcnamara sold 2,000 shares of the company’s stock in a transaction on Friday, May 1st. The stock was sold at an average price of $421.13, for a total transaction of $842,260.00. Following the completion of the transaction, the chief executive officer directly owned 90,219 shares in the company, valued at $37,993,927.47. This trade represents a 2.17% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. 3.33% of the stock is owned by insiders.

Chemed Price Performance

Shares of NYSE:CHE opened at $432.70 on Wednesday. The company’s fifty day moving average is $417.17 and its two-hundred day moving average is $424.24. The company has a quick ratio of 0.83, a current ratio of 0.85 and a debt-to-equity ratio of 0.11. Chemed Corporation has a 12-month low of $365.20 and a 12-month high of $562.77. The company has a market cap of $5.74 billion, a P/E ratio of 23.58, a price-to-earnings-growth ratio of 1.59 and a beta of 0.54.

Chemed (NYSE:CHE) last announced its earnings results on Thursday, April 23rd. The company reported $5.65 earnings per share (EPS) for the quarter, beating the consensus estimate of $5.30 by $0.35. Chemed had a net margin of 10.23% and a return on equity of 27.18%. The company had revenue of $657.51 million for the quarter, compared to the consensus estimate of $659.22 million. During the same period in the previous year, the business earned $5.63 EPS. The company’s revenue was up 1.6% on a year-over-year basis. Chemed has set its FY 2026 guidance at 24.000-24.75 EPS. Equities analysts expect that Chemed Corporation will post 22.3 earnings per share for the current fiscal year.

Chemed Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Tuesday, June 16th. Shareholders of record on Thursday, May 28th were paid a dividend of $0.60 per share. This represents a $2.40 annualized dividend and a yield of 0.6%. The ex-dividend date of this dividend was Thursday, May 28th. Chemed’s payout ratio is 13.08%.

Analysts Set New Price Targets

A number of brokerages have recently commented on CHE. Royal Bank Of Canada increased their price objective on Chemed from $422.00 to $436.00 and gave the company a “sector perform” rating in a research report on Monday, April 27th. Weiss Ratings upgraded Chemed from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Wednesday, April 29th. Zacks Research upgraded Chemed from a “strong sell” rating to a “hold” rating in a research report on Monday, April 27th. Oppenheimer cut their price objective on Chemed from $580.00 to $500.00 and set an “outperform” rating for the company in a research report on Friday, February 27th. Finally, Wall Street Zen downgraded Chemed from a “buy” rating to a “hold” rating in a research report on Monday, June 8th. Two research analysts have rated the stock with a Buy rating and four have given a Hold rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus price target of $501.50.

Chemed Profile

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.